Suppr超能文献

测量方法的选择:听力有问题者中EQ-5D、HUI2和HUI3的比较

Choosing between measures: comparison of EQ-5D, HUI2 and HUI3 in persons with hearing complaints.

作者信息

Grutters Janneke P C, Joore Manuela A, van der Horst Frans, Verschuure Hans, Dreschler Wouter A, Anteunis Lucien J C

机构信息

Department of Clinical Epidemiology and Medical Technology Assessment, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, The Netherlands.

出版信息

Qual Life Res. 2007 Oct;16(8):1439-49. doi: 10.1007/s11136-007-9237-x. Epub 2007 Jul 24.

Abstract

OBJECTIVES

To generate insight into the differences between utility measures EuroQol 5D (EQ-5D), Health Utilities Index Mark II (HUI2) and Mark III (HUI3) and their impact on the incremental cost-effectiveness ratio (ICER) for hearing aid fitting

METHODS

Persons with hearing complaints completed EQ-5D, HUI2 and HUI3 at baseline and, when applicable, after hearing aid fitting. Practicality, construct validity, agreement, responsiveness and impact on the ICER were examined.

RESULTS

All measures had high completion rates. HUI3 was capable of discriminating between clinically distinctive groups. Utility scores (n = 315) for EQ-5D UK and Dutch tariff (0.83; 0.86), HUI2 (0.77) and HUI3 (0.61) were significantly different, agreement was low to moderate. Change after hearing aid fitting (n = 70) for HUI2 (0.07) and HUI3 (0.12) was statistically significant, unlike the EQ-5D UK (0.01) and Dutch (0.00) tariff. ICERs varied from 647,209 euros/QALY for the EQ-5D Dutch tariff to 15,811 euros/QALY for HUI3.

CONCLUSION

Utility scores, utility gain and ICERs heavily depend on the measure that is used to elicit them. This study indicates HUI3 as the instrument of first choice when measuring utility in a population with hearing complaints, but emphasizes the importance of a clear notion of what constitutes utility with regard to economic analyses.

摘要

目的

深入了解效用测量工具欧洲五维健康量表(EQ - 5D)、健康效用指数第二代(HUI2)和第三代(HUI3)之间的差异,以及它们对助听器验配增量成本效果比(ICER)的影响

方法

有听力问题的患者在基线时完成EQ - 5D、HUI2和HUI3测评,适用时在助听器验配后再次测评。对实用性、结构效度、一致性、反应度以及对ICER的影响进行了检验。

结果

所有测评的完成率都很高。HUI3能够区分临床上不同的组别。EQ - 5D英国版和荷兰版量表的效用得分(n = 315)(分别为0.83和0.86)、HUI2(0.77)和HUI3(0.61)存在显著差异,一致性为低到中度。助听器验配后(n = 70),HUI2(0.07)和HUI3(0.12)的变化具有统计学意义,而EQ - 5D英国版(0.01)和荷兰版(0.00)量表则不然。ICER范围从EQ - 5D荷兰版量表的647,209欧元/QALY到HUI3的15,811欧元/QALY。

结论

效用得分、效用增益和ICER在很大程度上取决于用于得出这些结果所采用工具。本研究表明,在对有听力问题的人群进行效用测量时,HUI3是首选工具,但强调了在经济分析中对效用构成有清晰概念的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d5c/2039846/44505dfd5fa7/11136_2007_9237_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验